CINCINNATI , Sept. 09, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. , a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of two new Air-Dryable™ Master Mixes with the launch of its Air-Dryable™ Direct DNA qPCR Stool and

CINCINNATI , Sept. 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. , a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Air-Dryable™ Direct DNA qPCR Saliva and Air-Dryable™ Direct RNA/DNA qPCR Saliva Mixes, which

CINCINNATI, OH / ACCESSWIRE / September 1, 2021 /   Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. ("Magellan"), expanded the Class I recall of its LeadCare ®

CINCINNATI, OH / ACCESSWIRE / August 30, 2021 /   Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the H. C . Wainwright 23rd Annual Global Investment Conference .

CINCINNATI , Aug. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ) today announced financial results for the third quarter ended June 30, 2021 . Third Quarter 2021 Highlights (Comparison to Third Quarter Fiscal 2020): • Consolidated net revenues of $63.5 million , down 25%

CINCINNATI , Aug. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. , a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it closed the previously announced acquisition of the North American BreathTek ® business from Otsuka America

CINCINNATI , July 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. , a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a definitive agreement to acquire the North American BreathTek ® business from Otsuka America

CINCINNATI , July 14, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a provider of diagnostic testing solutions and life science raw materials, will report third quarter fiscal 2021 financial results Friday, August 6, 2021 . Jack Kenny , Chief Executive Officer, and Bryan

CINCINNATI , July 13, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a provider of diagnostic testing solutions and life science raw materials, today provided preliminary revenue results for its third quarter of fiscal 2021. Preliminary unaudited revenue for the third quarter

CINCINNATI , June 28, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. , a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has re-submitted its application for Emergency Use Authorization (EUA) to the U.S.